Cannon Global Investment Management, LLC Abeona Therapeutics Inc. Transaction History
Cannon Global Investment Management, LLC
- $49.7 Million
- Q1 2025
A detailed history of Cannon Global Investment Management, LLC transactions in Abeona Therapeutics Inc. stock. As of the latest transaction made, Cannon Global Investment Management, LLC holds 14,000 shares of ABEO stock, worth $74,760. This represents 0.13% of its overall portfolio holdings.
Number of Shares
14,000Holding current value
$74,760% of portfolio
0.13%Shares
1 transactions
Others Institutions Holding ABEO
# of Institutions
69Shares Held
28.7MCall Options Held
631KPut Options Held
2.9K-
Adage Capital Partners Gp, L.L.C. Boston, MA3.9MShares$20.8 Million0.04% of portfolio
-
Suvretta Capital Management, LLC New York, NY3.69MShares$19.7 Million0.85% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT3.53MShares$18.8 Million0.98% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.12MShares$11.3 Million0.01% of portfolio
-
Western Standard LLC Los Angeles, CA2.08MShares$11.1 Million7.9% of portfolio
About ABEONA THERAPEUTICS INC.
- Ticker ABEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 5,950,380
- Market Cap $31.8M
- Description
- Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-a...